EODData

LSE, 0QCO: Pharming Group NV Leiden Ord Shs

24 Aug 2026
LAST:

0.9850

CHANGE:
 0.01
OPEN:
1.0060
HIGH:
1.0060
ASK:
0.7710
VOLUME:
1.46M
CHG(%):
1.01
PREV:
0.9950
LOW:
0.9780
BID:
0.7335
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Aug 261.00601.00600.97800.98501.46M
21 Aug 260.99601.01800.98800.9950608.6K
20 Aug 261.01201.02800.99601.0080456.2K
19 Aug 260.98701.02200.98601.02001.02M
18 Aug 261.01901.02600.99201.0050636.6K
17 Aug 261.00401.02600.99001.02101.18M
14 Aug 261.02001.04000.99401.01201.11M
13 Aug 261.03701.04001.01501.02601.43M
12 Aug 260.98701.01500.97001.01001.71M
11 Aug 260.94800.99000.92400.99001.3M

PROFILE

Name:Pharming Group NV Leiden Ord Shs
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:57.03 
PEG Ratio:-0.84 
Price to Sales:3.82 
Price to Book:3.31 
Profit Margin:-0.08 
Operating Margin:-0.13 
Return on Assets:-0.04 
Return on Equity:-0.08 
EPS Ratio:0.02 
Revenue:176.26M 
EBITDA:42.65M 
Shares:638.56M 
Market Cap:628.98M 

TECHNICAL INDICATORS

MA5:1.001.8%
MA10:1.012.3%
MA20:0.980.4%
MA50:1.0911.1%
MA100:1.1819.6%
MA200:1.3132.9%
STO14:51.75
RSI14:67.65 
WPR14:-41.00
MTM14:0.06
ROC14:0.06 
ATR:0.04 
Week High:1.034.4%
Week Low:0.980.7%
Month High:1.1415.7%
Month Low:0.8332.9%
Year High:1.8385.5%
Year Low:0.8318.1%

RECENT SPLITS

Date Ratio
23 Nov 2016805-799
05 Mar 20131-10